Summary
This conference is aimed at researchers and clinicians, to increase awareness of gender difference in ADHD. With international speakers, the talks will cover a broad range of clinical, research and lived-experience expertise. The conference will be held at the Jubilee conference centre, all day including lunch. In the afternoon a workshop on establishing research and clinical priority will be conducted with the attendees.
Conference agenda
26th March 2026
9.30am – 3pm
In-person at the University of Nottingham Jubilee Conference Centre
Morning insights:
Morning talks from a range of UK and international speakers, including Dr Joanna Martin (Cardiff University), Dr Jasmin Wertz (University of Edinburgh), and Dr Lotta Borg Skoglund (Senior Consultant in Family Medicine & Psychiatry), covering themes including ADHD, pregnancy and parenting.
Networking lunch
Networking lunch to connect with peers, exchange ideas, and build collaborations.
Afternoon collaboration
A collaborative afternoon workshop focused on identifying future research and clinical priorities.
The full agenda will be updated soon
2025 conference details and priority report
This report summarizes our event on ADHD in girls and women. The event brought together 86 clinicians and researchers to discuss clinical and research implications, as well as lived experience perspectives. Key themes included the need to adapt clinical practice, develop gender-inclusive assessment tools, and address the challenges of navigating ADHD without a diagnosis.
The conference also included a priority-setting workshop, which resulted in ranked lists of research and clinical priorities to advance understanding and support for girls and women with ADHD. Research priorities included promoting early identification, developing inclusive assessment tools, understanding co-occurring conditions, and investigating medication use and hormonal influences. Clinical priorities focused on earlier identification, reducing waiting times, improving diagnostic tools, enhancing training for healthcare professionals and educators, and delivering individualized treatment. Full report of UK based research and clinical priorities can be found in the document below:

